Are you aiming for an entry-level role in pharmaceuticals or medical technology? Do you want to strengthen your resume with in-demand regulatory affairs expertise?
The Office of Regulatory Affairs and Quality invites you to enroll in the Spring 2026 ORAQ Regulatory Affairs Training Program—a dynamic, beginner-friendly course designed to give you a solid foundation in premarket FDA regulatory processes for drugs, biologics, and medical devices.
What You’ll Learn
By the end of this program, you’ll walk away with:
- A clear understanding of drug, biologic, and medical device development
- Practical knowledge of INDs and IDEs—including their content, format, and maintenance
- Proven strategies for conducting successful meetings with the FDA
Whether you're a student, recent graduate, or professional exploring a new path, this program is open to everyone—no prior experience required!
How to Register?
Click here to register:
Register
Registration closes March 25, 2026 at 9:00 AM ET.
Program Details
- Start Date: March 27, 2026
- End Date: May 1, 2026
- Time: 9:00 AM ET – 10:00 AM ET once each Friday
- Format: Six weekly 1-hour Zoom lectures
- Access: Recordings available for 12 weeks post-program (view-only); slides downloadable
- Time Zone: Eastern Time (ET)
Weekly Schedule & Topics
| Week | Date | Topic |
|---|---|---|
| Week 1 | March 27, 2026 | Drug Development and FDA Meetings |
| Week 2 | April 3, 2026 | Applicability of FDA Drug Regulations to Clinical Studies |
| Week 3 | April 10, 2026 | IND Content, Format, Review and Maintenance |
| Week 4 | April 17, 2026 | Medical Device Development and FDA Meetings |
| Week 5 | April 24, 2026 | Applicability of FDA Device Regulations to Clinical Studies |
| Week 6 | May 1, 2026 | IDE Preparation, Submission, and Maintenance |
Cost
The cost to participate in the program is $200 payable by credit card only. No refunds will be provided after registration.
Certificate of completion
Complete the program quiz and receive a certificate of completion—a great addition to your resume or LinkedIn profile.
Questions?
Please visit our page for frequently asked questions.